Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute Renal Failure With Cocaine and SGLT-2 Inhibitor.
Shrivastava S, Srivastava N, Alfanso-Jaume M. Shrivastava S, et al. Am J Ther. 2019 Nov/Dec;26(6):e762-e763. doi: 10.1097/MJT.0000000000000929. Am J Ther. 2019. PMID: 31425163 No abstract available.
Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment.
Verma A, Waiker DK, Singh N, Singh A, Saraf P, Bhardwaj B, Kumar P, Krishnamurthy S, Srikrishna S, Shrivastava SK. Verma A, et al. Among authors: shrivastava sk. Eur J Med Chem. 2024 Apr 27;271:116450. doi: 10.1016/j.ejmech.2024.116450. Online ahead of print. Eur J Med Chem. 2024. PMID: 38701714
Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates against Alzheimer's Disease with Antioxidant Potential.
Singh A, Verma A, Bhardwaj B, Saraf P, Kumar H, Jain N, Waiker DK, Gajendra TA, Krishnamurthy S, Shrivastava SK. Singh A, et al. Among authors: shrivastava sk. ACS Omega. 2024 Apr 11;9(16):18169-18182. doi: 10.1021/acsomega.3c10276. eCollection 2024 Apr 23. ACS Omega. 2024. PMID: 38680351 Free PMC article.
Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
Waiker DK, Verma A, Gajendra TA, Namrata, Roy A, Kumar P, Trigun SK, Srikrishna S, Krishnamurthy S, Davisson VJ, Shrivastava SK. Waiker DK, et al. Among authors: shrivastava sk. Eur J Med Chem. 2024 Apr 16;271:116409. doi: 10.1016/j.ejmech.2024.116409. Online ahead of print. Eur J Med Chem. 2024. PMID: 38663285
1,318 results